Table 4 Multivariate analysis of the factors related to metastasis.

From: Fluorescence in situ hybridization detection of chromosome 7 and/or 17 polysomy as a prognostic marker for cholangiocarcinoma

Variables

Multivariate (backward)

OR

95% CI

P-value

Lymph node metastasis

Anatomical position (intrahepatic/extrahepatic)

3.249

1.412–7.478

0.006

Gross pathology (ID/PI)

3.427

1.000–11.749

0.050

Gross pathology (ID /MF)

2.884

0.834–9.974

0.094

Gross pathology (ID/mixed)

3.174

0.948–10.630

0.061

C7 (disomy/trisomy)

3.496

1.306–9.359

0.013

C7 (disomy/ > trisomy)

6.944

2.695–17.896

 < 0.001

C17 (disomy/trisomy)

1.707

0.348–8.386

0.510

C17 (disomy/ > trisomy)

1.478

0.253–8.642

0.665

C7/17 (disomy/trisomy)

4.488

1.284–15.682

0.019

C7/17 (disomy/ > trisomy)

6.723

2.663–16.973

 < 0.001

GB metastasis

Anatomical position (intrahepatic/extrahepatic)

4.473

1.398–14.309

0.012

Gross pathology (ID/PI)

0.745

0.178–3.119

0.687

Gross pathology (ID /MF)

4.763

1.252–18.120

0.022

Gross pathology (ID/mixed)

1.637

0.437–6.134

0.465

C7 (disomy/trisomy)

C7 (disomy/ > trisomy)

12.722

2.848–56.824

0.001

C17 (disomy/trisomy)

1.215

0.102–14.465

0.877

C17 (disomy/ > trisomy)

9.515

2.098–43.148

0.003

C7/17 (disomy/trisomy)

1.209

0.101–14.512

0.881

C7/17 (disomy/ > trisomy)

8.000

1.707–37.486

0.008

Distant metastasis

Anatomical position (intrahepatic/extrahepatic)

Gross pathology (ID/PI)

1.059

0.164–6.815

0.952

Gross pathology (ID/MF)

5.921

1.055–33.224

0.043

Gross pathology (ID/mixed)

1.457

0.238–8.927

0.684

C7 (disomy/trisomy)

1.142

0.069–18.858

0.926

C7 (disomy/ > trisomy)

0.358

0.017–7.572

0.509

C17 (disomy/trisomy)

6.576

0.397–108.876

0.188

C17 (disomy/ > trisomy)

31.130

1.609–602.161

0.023

C7/17 (disomy/trisomy)

10.037

0.922–109.229

0.058

C7/17 (disomy/ > trisomy )

17.076

2.119–137.615

0.008